Related by context. All words. (Click for frequent words.) 62 phase III ACCLAIM 61 using BioSante patented 61 Prodarsan R 61 kidney urologic 60 including eniluracil ADH 60 trastuzumab DM1 T DM1 60 recombinant biopharmaceutical 60 HepDirect R 60 therapeutic monoclonal antibody 60 Kosan dependence 59 Celacade TM 59 acetonide FA 59 multicenter Phase II 59 rotary VAD 59 targeted radiotherapeutic 59 INS# [001] 59 EHT AGN 59 Transdrug ® nanoparticle 59 Bioaccelerate compounds under 59 delivery polymer matrix 59 Currently RegeneRx 58 NuMimetic TM 58 CYT# potent vascular disrupting 58 MelaFind R 58 Surfaxin LS 58 BrachySil TM 58 platinum chemotherapeutic 58 BACcel 58 OLIGON technology 58 phase IIb clinical 58 product platforms AZX# 58 anti infective treatments 58 FOLOTYN ® 58 Provectus Pharmaceuticals specializes 58 IIa clinical trials 58 use neuroblocking technology 58 oral ghrelin agonist 58 Protexia ® 58 QTinno TM 58 candidate XP# 58 REMOXY R 58 ospemifene 58 PDE# inhibitors 58 Bayer HealthCare Onyx Pharmaceuticals 58 candidate CRLX# 58 REGEN trial 58 Bioral Amphotericin B 58 Selective Electrochemical Tumor Ablation 57 anticancer therapeutics 57 Enhanze 57 candidate TNFerade biologic 57 trastuzumab DM1 57 Progenta TM 57 transmucosal delivery 57 INTERCEPT red 57 AdhTAP 57 commercializing interventional 57 ancrod 57 serine protease inhibitor CU# 57 Spiegelmer ® 57 oral transdermal 57 Myocet 57 NP2 Enkephalin 57 manufacturing interventional vascular 57 NTDDS 57 Prodarsan ® 57 antibiotic candidate Ramoplanin 57 Homspera TM 57 adrenergic regulation 57 VITAL Trial 57 bardoxolone 57 Phase #b/#a clinical 57 EP #R 57 skeletal sarcomere activators 57 XP #L 57 eSVS MESH 57 PORxin TM platforms 57 using ImmunoGen TAP 57 proprietary capillary aerosolization 57 ONCONASE R 57 pharmaceuticals biologics 57 HuMax TAC 57 RSD# oral 57 Locked Nucleic Acid 57 novel immunotherapies 57 biased ligand 57 constipation OIC 57 Iluvien ® 57 resorbable biomaterials 56 ALN PCS 56 Zemiva TM 56 monoclonal antibody therapeutics 56 TBC# 56 theranostic 56 QNEXA ® 56 punctal plug delivery 56 dirucotide MBP# 56 systemic RNAi 56 REMOXY ® 56 Cleviprex TM clevidipine 56 CBLC# 56 Ceragenin ™ technology 56 personalized cellular immunotherapy 56 cGMP manufacture 56 Allovectin 7 56 BioSilicon TM 56 Vascular Wrap TM 56 Stimuvax R 56 lipid nanoparticle 56 Rhucin ® recombinant 56 synthetic retinoid 56 visit http:/www.mannkindcorp.com 56 MabThera rituximab 56 aerosolized AAT 56 ophthalmic therapeutics 56 therapeutic monoclonal antibodies 56 Peyronie disease Frozen Shoulder 56 Locked Nucleic Acid LNA 56 Phase IIb III 56 ABthrax TM raxibacumab 56 Dyax phage display 56 reslizumab 56 AdVac R 56 CA9 SCAN 56 external counterpulsation systems 56 vaginally administered lidocaine 56 Solazed 56 THR beta agonist 56 Unit Dose Budesonide 56 Alnylam RNAi 56 ketolide antibiotic 56 delivers fluocinolone acetonide FA 56 recombinant protein therapeutics 56 OHR/AVR# 56 PrevOnco ™ 56 oral PTH 56 AEG# 56 RenaZorb TM 56 proprietary MSCRAMM protein 56 punctal plug drug 56 Solazed TM 56 neuroblocking technology 56 EOS NASDAQ MELA 56 AE# vaccine 56 Proellex TM 56 Bioenvision compounds under 56 orally inhaled migraine 56 oral methylnaltrexone 56 Captisol ® 55 PRESEPT study 55 ARIKACE ™ 55 RECALL VAX vaccine 55 EndoTAG TM 55 opioid induced bowel dysfunction 55 intranasal insulin product 55 Bioral ® 55 P#X# antagonist 55 utilize proton beam 55 proprietary bioresorbable polymer 55 Litx 55 Evoltra ® 55 POWERSTACK tm MC# 55 leading oral taxane 55 Anticalins R 55 rusalatide acetate 55 diagnostics therapeutics 55 thetreatment 55 Soliris eculizumab 55 Hepatocellular Carcinoma HCC 55 POSIDUR TM ELADUR TM 55 tPEMF tm 55 proprietary transdermal 55 MGd 55 GeneICE 55 GED aPC 55 therapeutic peptide 55 transfection reagents 55 Ipsen Euronext IPN 55 phase Ib clinical 55 XL# XL# 55 ophthalmology dermatology cardiovascular disease 55 TELINTRA R 55 Nanobody ® 55 PNP inhibitor 55 Ketotransdel 55 AQUA ® 55 mecarbil 55 ALN TTR# 55 gastro intestinal inflammation 55 TELINTRA 55 iPSC technology 55 introduced NEUGENE 55 Puricase PEG uricase 55 YONDELIS 55 LentiVector 55 muscarinic receptor agonists 55 acute decompensated heart 55 generation NEUGENE antisense 55 OncoGel 55 novel therapeutic antibodies 55 Cloretazine ® 55 AcryMed Incorporated 55 HGS# 55 recombinant PSMA vaccine 55 optical biosensors 55 proprietary Biochronomer 55 microRNA profiling 55 pafuramidine maleate 55 Phase #b/#a 55 Phase IIb clinical trials 55 MKC# MT 55 Diamyd R 55 Nanobody R 55 LymphoStat B belimumab 55 R PEG uricase 55 SEPET TM 55 OncoVex 55 Pancreate 55 Squalamine 55 TRANSDUR ™ 55 Spiegelmer 55 treat chronic sinusitis 55 Plasma Converter TM 55 Lipid Polymer Micelle LPM 55 rxRNA 55 predictive biomarkers 55 acyclovir Lauriad R 55 HIV maturation inhibition 55 ELADUR TM 55 HepaMate 54 Inc. OTCBB IRBS 54 patented Bioral 54 nalbuphine ER 54 Optiquel ™ 54 dextofisopam 54 immunotherapies 2A/Furin 54 NeuroFlo 54 Oasmia 54 TriGrid 54 Lymphoseek ® 54 Genedata Expressionist ® 54 bioprocesses 54 vernakalant hydrochloride 54 biotherapeutic drugs 54 receptor tyrosine kinase inhibitor 54 Inc. Nasdaq NLTX 54 ELADUR ™ 54 REG1 54 Phase Ib II 54 Alfacell proprietary ribonuclease 54 ZaBeCor 54 PN# [001] 54 R#/MEM 54 Ostabolin C TM 54 epothilone 54 Phase lll 54 Cellgate patented transporter 54 candidate AQ4N 54 Lofexidine 54 dSLIM 54 Levulan ® PDT 54 optimal dosing regimens 54 EV# vaccine 54 product Zingo TM 54 GEM OS2 54 aerosolized KL4 surfactant 54 novel antiviral therapeutics 54 DNA methylation biomarkers 54 immunotherapeutic vaccine 54 acne impetigo 54 Generx TM 54 PATHFINDER ® 54 ulimorelin 54 RECOTHROM R 54 oncolytic virus therapies 54 VitroGro 54 Aurexis 54 intravenous AAT 54 PD2i Analyzer 54 commercializing therapeutic 54 ZEFTERA TM Zevtera TM 54 patented NanoStat ™ 54 HCV protease inhibitors 54 TQT studies 54 diabetes irritable bowel 54 Nanobody 54 prostone 54 eTag assays 54 ASONEP TM 54 cardio renal 54 Val HeFT 54 Cx# [002] 54 Symphony tCGM 54 ACTCellerate 54 MAXY VII 54 Azedra 54 proprietary biomaterials 54 sodium thiosulfate STS 54 initiated Phase Ib 54 Etubics 54 Cobalamin TM mediated 54 TFChem licenses 54 IMA# 54 Dacetuzumab 54 ProCord 54 GI motility disorders 54 drug GAP #B# 54 invasive candidiasis 54 Biopump 54 MYDICAR 54 MAGE A3 ASCI 54 fatty acid amide hydrolase 54 VersaFilm 54 generation purine nucleoside 54 therapeutics diagnostics 54 LNP formulations 54 candidate NGX 54 commercialize Aganocides 54 pain palliation 54 GeoVax AIDS vaccine 54 Lixivaptan 54 Zavesca r 54 Ibis T# 54 PORxin TM 54 torsemide ER 54 TRANSDUR TM Sufentanil 54 Corlux 54 Novolimus 54 proprietary intranasal insulin 54 Personalized Immunotherapy 54 vivo fluorescence imaging 54 isoform selective 54 glucokinase activator 54 Intraject 54 PHX# 54 TOCOSOL 54 IL# PE#QQR 54 electrochemical separations 54 INOmax R 53 liposomal formulation 53 Dalbavancin 53 MediGene focuses 53 molecular imaging radiopharmaceutical 53 XmAb ® 53 Durata 53 validating biomarkers 53 Onalta 53 covering SNALP 53 forodesine 53 NASDAQ BTRX pharmaceutical 53 CHAMPION PCI 53 CholeraGarde R 53 rALLy clinical trial 53 commercialize conjugates consisting 53 recurrent metastatic ovarian cancer 53 OvaRex ® MAb 53 phase IIb trial 53 factor VIIa 53 INTERCEPT platelets 53 EMPOWER ™ 53 gynecologic procedures 53 molecular chaperone regulation 53 tiapamil 53 BEMA TM 53 rPA anthrax vaccine 53 transdermal insulin 53 Oncaspar 53 PER.C6 ® cell 53 ESPRIT therapy 53 budesonide MMX Phase III 53 vaccines oncolytic virus 53 MIST II 53 UVIDEM 53 Phase III Pivotal 53 ADVANCE PD 53 PARI Pharma focuses 53 candidate Zemiva TM 53 Civacir 53 XmAb 53 ionotropic glutamate receptor antagonists 53 romazarit 53 Thorough QT 53 research anddevelopment 53 Veronate 53 adipose derived stem cell 53 CURE AF 53 AcryMed technologies 53 catheter occlusion 53 Bavarian Nordic patented 53 phase IIa clinical 53 Chimigen 53 Factor VIIa 53 fluorinated carbohydrate mimics 53 molecular imaging radiopharmaceuticals 53 MOVIPREP R 53 kinase profiling 53 Mipomersen 53 PRIMO CABG 53 ALTROPANE R 53 liposomal delivery 53 oral NKTR 53 SUMAVEL 53 cancer immunotherapies 53 successfully commercialize Iluvien 53 vivo glucose 53 Transdel TM 53 HepeX B 53 LabCorp combines 53 bipolar wafer 53 EXPLORE Xa 53 RECOTHROM ® 53 Rheos System 53 PROGENSA R 53 hypoxia activated prodrug 53 DXL# 53 LymphoStat B TM 53 randomized controlled multicenter 53 treat male hypogonadism 53 Cutanea 53 photodynamic therapy dermatology 53 CD# CEA 53 Exherin TM 53 Pyridorin 53 CytoFabTM 53 vemurafenib 53 IV acetaminophen 53 Exelixis compounds 53 FVIIa 53 EVIZON TM squalamine lactate 53 ALN RSV program 53 immunological diseases 53 staphylococcal vaccine 53 Altera Nebulizer System 53 proprietary GelSite R 53 GALNS N acetylgalactosamine 53 Edwards SAPIEN valve 53 refractory angina 53 epigenetic therapies 53 GPR# agonist 53 GM DUSA dermatology 53 treat lupus renal 53 Perceiva 53 ChronVac C R 53 RNA interference RNAi therapeutics 53 NPC 1C 53 lorvotuzumab mertansine 53 Prednisporin TM 53 pivotal bioequivalence 53 BEMA TM Fentanyl 53 Ozarelix 53 buccal delivery 53 ERYtech 53 mSEPT9 biomarker 53 Cell TRC 53 intranasal vaccines derived 53 next generation URAT1 53 plasmid DNA pDNA 53 ThermaVolt 53 POSIDUR ™ 53 overactive bladder AA# 53 RenalGuard System TM 53 Fibrin Pad 53 recombinant factor VIIa 53 PK PD modeling 53 Bioral 53 molecular imaging pharmaceuticals 53 NovaDel oral spray 53 SUTENT ® 53 immunotherapeutics 53 Phase IIIB IV 53 #L Ozone Sterilizer 53 DOS# 53 HCD# [002] 53 Ceplene TM 53 SEQureDx TM 52 OTCBB NRGX biotechnology 52 Tesetaxel 52 Ampakine compounds 52 Allovectin 7 r 52 non nucleoside 52 oxypurinol 52 Opterone R 52 bioartificial liver 52 UltiMAb 52 HuCAL antibody 52 novel peptides 52 AERx iDMS 52 OvaRex R 52 Phase Ib clinical 52 GSK# [002] 52 proprietary PEGylation 52 developing TB4 52 Xcytrin R 52 vitreoretinal disorders 52 ReCyte 52 Quinamed 52 Cerashield TM 52 Prednisporin 52 Testosterone MDTS R 52 recurrent herpes labialis 52 rThrombin 52 ATL# [002] 52 Fodosine 52 RELISTOR ® 52 selective androgen receptor modulator 52 Hemopurifier 52 photodisinfection 52 RhuDex ® 52 LentiVector technology 52 EVIZON TM 52 ABSORB clinical 52 Staccato nicotine technology 52 Micromet BiTE 52 fosbretabulin 52 Collategene 52 metabolite identification 52 targeted anticancer biopharmaceuticals 52 candidate deforolimus 52 treat refractory angina 52 Ceragenin ™ 52 inhaled AAT 52 proprietary BiTE ® 52 Albugon 52 YONDELIS R 52 tramiprosate ALZHEMED TM 52 Bicifadine 52 MorphoSys proprietary 52 Æterna Zentaris Inc. 52 Bellicum 52 OTCBB AEMD pioneer 52 biomarker assay development 52 Ceflatonin R 52 AKIP ™ 52 personalized immunotherapy 52 Crucell PER.C6 ® 52 ostarine 52 buccal soluble film 52 Nanobodies ® 52 recombinant antibodies 52 REMINYL ® 52 Loramyc ™ 52 Nasdaq IDIX biopharmaceutical 52 KL4 surfactant 52 intracellular targeting 52 menstrual stem cell 52 velafermin 52 Brussels THR 52 oral prodrug 52 volociximab 52 inflammatory autoimmune diseases 52 NanoAir 52 Fibrocaps 52 Neurostep TM 52 ularitide 52 Loramyc TM 52 chemical entities NCEs 52 INxin TM 52 polyurethane elastomer tire 52 Photodynamic Therapy PDT 52 NurOwn 52 development peramivir neuraminidase 52 NovaBay Aganocide compounds 52 TIMERx 52 riociguat 52 biomarker identification 52 Lauriad 52 vinca alkaloid 52 BioFocus DPI Galapagos 52 cathepsin K inhibitor 52 hepatitis B vaccine Heplisav 52 Preotact R 52 Pepducin 52 Oral NKTR 52 molecular diagnostic assays 52 GLP toxicology 52 Voraxaze ™ 52 Onco TCS 52 celgosivir 52 Archexin 52 Levacor 52 recombinant vaccines 52 phase IIb III 52 novel oral anticoagulant 52 Phase IIa trials 52 oral taxane 52 Lu AA# 52 elotuzumab 52 intravenous methylnaltrexone 52 Potelligent Technology 52 mechanical thrombectomy 52 rALLy 52 Neuradiab 52 preclinical toxicology 52 investigational therapies 52 CDAD Clostridium difficile 52 solanezumab 52 KL4 Surfactant 52 Omigard 52 clinical pharmacology studies 52 Rasagiline 52 XL# anticancer compounds 52 INTEGRILIN R eptifibatide Injection 52 PSMA ADC 52 Cloretazine 52 mild vasodilator 52 Zevalin consolidation 52 ArQule Kinase Inhibitor Platform 52 BRIM3 52 INOmax 52 dacetuzumab 52 Tectin TM 52 Oncobionic 52 peptide synthesis 52 Sennheiser pioneering 52 TLK# 52 generation biocompatible coatings 52 Entereg R 52 delta opioid receptor 52 commercialize MDV# 52 initiate multicenter 52 MEND CABG II 52 Tekmira lipid nanoparticle 52 JAK2 inhibitor 52 MEND CABG 52 placebo controlled Phase III 52 thorough QT 52 Cloretazine R 52 tubulin inhibitor 52 Intermezzo ® zolpidem tartrate 52 RapidResponse TM DNA 52 Fentanyl Taifun 52 adecatumumab MT# 52 Hedgehog agonist 52 Quotient Bioresearch 52 Tyzeka Sebivo 52 budesonide foam 52 immunodiagnostics 52 molecular diagnostic kits 52 autologous cellular therapies 52 Dr. Cookenboo 51 Phase Ib clinical trials 51 microplasmin Phase III 51 Targeted Chemotherapy 51 use transdermal sumatriptan 51 Aganocide ® 51 fidaxomicin Phase 3 51 Fabry Disease 51 tranilast 51 blood clot dissolver 51 Fentanyl TAIFUN R 51 Sentient specializes 51 Chipscreen 51 IIa clinical 51 Neo Kidney Augment 51 oral talactoferrin 51 Xcellerated T Cells 51 Neo Kidney Augment ™ 51 AA Amyloidosis 51 Annamycin 51 Rhucin R 51 Diamyd ® 51 peptide peptide mimetic 51 Aquinox 51 Urocidin TM 51 IV APAP 51 Soliris TM eculizumab 51 AFRS TM 51 proprietary Customized Linker 51 ZFNs clinical trials 51 CardioFit 51 alvespimycin 51 EGS# 51 PER.C6 r 51 EndoTAG TM -1 51 Fc fusion protein 51 Staccato loxapine 51 platforms GVAX 51 ASX PGL 51 transmucosal delivery system 51 Shigamabs ® 51 registrational Phase 51 Frozen Shoulder syndrome Adhesive 51 Aethlon Hemopurifier ® 51 pharmacogenetic tests 51 clevidipine 51 Bioral Amphotericin B. 51 SILENOR 51 Tarvacin Anti Cancer 51 Urocortin 2 51 individualized cellular immunotherapy 51 UltiMAb ® 51 subcutaneous RELISTOR 51 CINTREDEKIN BESUDOTOX 51 Adnectin 51 genomic biomarker 51 NeutroSpec TM 51 lomitapide 51 opioid bowel dysfunction 51 Onalta ™ 51 MGN# 51 Vicinium TM 51 Angiocept 51 Trofex 51 Zenvia ™ 51 Biophan MRI 51 small molecule PEGylation 51 subcutaneous methylnaltrexone 51 pharmacological therapies 51 nicotinic alpha 7 51 TransMID 51 SNALP technology 51 siRNA therapeutics 51 PDE4 inhibitor 51 PREVU i 51 dexanabinol 51 candidate brentuximab vedotin 51 AERx 51 unique PER.C6 51 Surfactant Replacement Therapies SRT 51 proprietary bioengineered microsphere 51 oral RSD# 51 motexafin gadolinium Injection 51 ALS #-# 51 BioLineRx clinical 51 novel antibody therapeutics 51 midstage clinical 51 InterfeRx TM 51 pharmaceuticals nutritionals 51 precommercial 51 CRMD# 51 Phase Ib IIa 51 smallpox vaccine IMVAMUNE R 51 EECP R 51 biocatalytic 51 novel L DOS# 51 Nicole Onetto MD 51 predictive toxicology 51 topical dermatology 51 RIGScan CR 51 MPH AMEX 51 Neovasc Reducer 51 JP-#/fipamezole 51 lixivaptan 51 SCENESSE ® 51 JUVISTA 51 Curaxin 51 POTELLIGENT ® 51 DIFICID ™ 51 SinuNase TM 51 rheumatoid arthritis thrombocytopenia 51 Cardium Therapeutics TM 51 AsepticSure 51 utilizing magnetically responsive 51 CRD5 51 AzaSite Xtra 51 acute mania 51 cangrelor 51 inhalation toxicology 51 Glassia 51 candidate Zemiva 51 Pervasis 51 noninfectious uveitis 51 Fx #A 51 Gentamicin Surgical Implant 51 peptide therapeutics 51 Nanomedicine Nanomedicine 51 luliconazole 51 FEDMFC 51 novel peptide therapeutics 51 Amoxicillin PULSYS Phase III 51 topically delivered 51 GEM #S 51 ddRNAi 51 ZFP Therapeutics 51 drug ISA# 51 noninvasive prenatal tests 51 LUVENIQ 51 TEMSO 51 Aganocide 51 non alcoholic steatohepatitis 51 GGF2 51 Intarcia 51 ZYBRESTAT fosbretabulin 51 relapsed multiple myeloma 51 subcutaneous immunoglobulin 51 Symphony tCGM System 51 initiate Phase 1b 51 vivo preclinical 51 selective androgen receptor modulators 51 Galenea 51 6 sulfatase 51 Thelin tm 51 candidate Zenvia 51 TRIST study 51 Fleximer R 51 CNP# 51 APEX PD 51 STEDESA 51 HepDirect 51 patented Bioral R nanocochleate 51 Glybera R 51 ORADUR ADHD 51 product Fentanyl TAIFUN 51 syndrome carcinoid syndrome 51 XP# XP# 51 midstage studies 51 AIM OBP 51 IFS 2C 51 StaphVAX R 51 Aplidin 51 rindopepimut 51 Aerosurf 51 Tomophase 51 Phase 2a clinical trials 51 GCP compliant 51 product ColonSentry TM 51 TP# CETi 1 51 ReN# 51 eSensor detection technology 51 gefitinib Iressa 51 gepirone ER 51 QTinno 51 biliary tract cancer 51 OraTest R 51 Bellicum Pharmaceuticals Inc. 51 diagnostic molecular imaging 51 Dacogen injection 51 PREOS R 51 stent coating 51 CINQUIL 51 Renal Cell Carcinoma RCC 51 diagnostic prognostic 51 product platforms GVAX 51 selective GR 51 small molecule glucokinase 51 Thrombin topical Recombinant 51 include VALSTAR TM 51 BR.# 51 modified glutathione analog 51 Vantas 51 HIV integrase inhibitors 51 noninvasive diagnostic 51 opioid induced constipation 51 Eligard ® 51 StemEx R 51 commercializing anti infective 51 homocysteine assay 51 Rheoscience 51 Thiarabine 51 Desmoteplase 51 candidate Puricase 51 Crucell PER.C6 51 CATALYST PHARMACEUTICAL PARTNERS INC. 51 Lupuzor 51 Prochymal TM 50 Atrigel 50 GRN# 50 phase IIb study 50 AN# novel 50 Roche SWX ROG 50 treat GI GVHD 50 FORMA Therapeutics 50 lumiliximab 50 #L Sterilizer 50 ZEVALIN ® 50 clinical 50 Dataflow Manager 50 novel RNAi therapeutics 50 orthobiologic 50 Relivar 50 Memory MRAM 50 zolpidem tartrate sublingual tablet 50 cystinosis patients 50 punctal plug 50 interventional vascular technology 50 LAB Pharma 50 Stedivaze 50 Proxinium TM 50 OTC XDSL develops 50 double blinded randomized 50 prenatal diagnostics 50 schizophrenia CIAS 50 postapproval 50 nanomedical 50 antibiotic telavancin 50 endocrinology oncology 50 Chrysalin r rusalatide acetate 50 NEUGENE R 50 OnDose TM 50 severe hypercholesterolemia 50 Silicon CMOS Photonics 50 Sylvie Gregoire President 50 Nautilus Biotech 50 Ceragenin 50 pharmacological chaperone 50 intranasal formulation 50 Muscle Pattern Recognition MPR 50 isavuconazole 50 nanomedicines 50 IV melanoma 50 Isis antisense 50 oral antiviral 50 purinergic receptors P#X# 50 POSIDUR TM 50 dietary supplement formulated 50 Sensient employs advanced 50 Poly ICR 50 cardiovascular metabolic 50 EchoCRT 50 SuperPolymer ® battery 50 beta secretase inhibitors 50 postoperative ileus POI 50 alemtuzumab MS 50 Oxygent 50 Syndax Pharmaceuticals Inc. 50 FavId 50 PyraDerm TM 50 PRT# 50 targeted pulsed electromagnetic 50 IMC #B 50 PLK1 SNALP 50 eniluracil 50 GLP toxicology studies 50 staphylococcal vaccines 50 called Fairpole 50 TRAIL receptor antibody 50 rFactor XIII 50 p# inhibitor 50 Prima BioMed 50 Expression BCE 50 ganaxolone 50 EGEN 50 Rezular 50 Phase 1a clinical 50 biocompatible coatings 50 herpetic keratitis 50 oxymorphone ER 50 lenalidomide Revlimid R 50 Phase #/#a 50 Phase IIIb study 50 AQ4N 50 RONDEL ™ 50 Endotis 50 intravenous acetaminophen 50 Additionally Soligenix 50 embedded multicore processors 50 NYSE Amex PBTH 50 MyVax personalized immunotherapy 50 UMTS EDGE GPRS GSM 50 clinical trials SGN 50 interventional pulmonology 50 unique PER.C6 ® 50 Phase IIB 50 delivers sumatriptan 50 trazodone hydrochloride 50 sirtuin modulators 50 JAK inhibitor 50 IIa trials 50 Ibis T# TM 50 octreotide implant 50 anti CD3 monoclonal 50 BioLineRx advances 50 pharmacokinetic PK study 50 Capsulution 50 antibody humanization 50 ALN HTT 50 Panzem R NCD 50 transcutaneous immunization TCI 50 Ferring Pharmaceuticals specializes 50 BioSilicon 50 Circ Pharma 50 TKM ApoB 50 midstage clinical trials 50 LUX Lung 50 randomized discontinuation 50 Shigamabs R 50 CLORETAZINE TM VNP#M 50 Itero 50 omecamtiv mecarbil 50 OTCBB PYTO 50 vosaroxin 50 Shigamabs 50 BST CarGel R 50 DURIN TM 50 EVIZON ™ 50 iCardiac 50 using VIAdel TM 50 Inc. Nasdaq VIAP 50 Ophena 50 Inotek Pharmaceuticals Corporation 50 OncoVEX 50 phase IIa 50 SNT MC# 50 neratinib 50 outlicense 50 Hedgehog antagonist 50 NeoVisc R 50 #G/#.#G GSM GPRS CDMA1X 50 patented BEMA